You must subscribe to access archives older
than one year.
Take a free trial of Briefing In Play® now.
Subscribe Here
TERMS OF USE

The Briefing.com RSS (really simple syndication) service is a method by which we offer story headline feeds in XML format to readers of the Briefing.com web site who use RSS aggregators. By using Briefing.com’s RSS service you agree to be bound by these Terms of Use. If you do not agree to the terms and conditions contained in these Terms of Use, we do not consent to provide you with an RSS feed and you should not make use of Briefing.com’s RSS service. The use of the RSS service is also subject to the terms and conditions of the Briefing.com Reader Agreement which governs the use of Briefing.com's entire web site (www.briefing.com) including all information services. These Terms of Use and the Briefing.com Reader Agreement may be changed by Briefing.com at any time without notice.

Use of RSS Feeds:
The Briefing.com RSS service is provided free of charge for use by individuals, as long as the feeds are used for such individual’s personal, non-commercial use. Any other uses, including without limitation the incorporation of advertising into or the placement of advertising associated with or targeted towards the RSS Content, are strictly prohibited. You are required to use the RSS feeds as provided by Briefing.com and you may not edit or modify the text, content or links supplied by Briefing.com. To acquire more extensive licensing rights to Briefing.com content please review this page.

Link to Content Pages:
The RSS service may be used only with those platforms from which a functional link is made available that, when accessed, takes the viewer directly to the display of the full article on the Briefing.com web site. You may not display the RSS content in a manner that does not permit successful linking to, redirection to or delivery of the applicable Briefing.com web site page. You may not insert any intermediate page, “splash” page or any other content between the RSS link and the applicable Briefing.com web site page.

Ownership/Attribution:
Briefing.com retains all ownership and other rights in the RSS content, and any and all Briefing.com logos and trademarks used in connection with the RSS service. You are required to provide appropriate attribution to the Briefing.com web site in connection with your use of the RSS feeds. If you provide this attribution using a graphic we require you to use the Briefing.com web site logo that we have incorporated into the Briefing.com RSS feed.

Right to Discontinue Feeds:
Briefing.com reserves the right to discontinue providing any or all of the RSS feeds at any time and to require you to cease displaying, distributing or otherwise using any or all of the RSS feeds for any reason including, without limitation, your violation of any provision of these Terms of Use or the terms and conditions of the Briefing.com Reader Agreement. Briefing.com assumes no liability for any of your activities in connection with the RSS feeds or for your use of the RSS feeds in connection with your web site.

Briefing.com
Subscribers Log In
 
  • HOME
  • OUR VIEW
    • Page One
    • The Big Picture
    • Ahead of the Curve
  • ANALYSIS
    • Premium Analysis
    • Story Stocks
  • MARKETS
    • Stock Market Update
    • Bond Market Update
    • Market Internals
    • After Hours Report
    • Weekly Wrap
  • CALENDARS
    • Upgrades/Downgrades
    • Economic
    • Stock Splits
    • IPO
    • Earnings
    • Conference Calls
    • Earnings Guidance
  • EMAILS
    • Edit My Profile
  • LEARNING CENTER
    • About Briefing.com
    • Ask An Analyst
    • Analysis
    • General Concepts
    • Strategies
    • Resources
    • Video
  • COMMUNITY
    • Twitter
    • Facebook
    • LinkedIn
    • YouTube
    • RSS
  • SEARCH
Login | Archive | EmailEmail |
HOME > Our View >Page One >More Medicine, but Will it...
Page One Archive
Last Update: 06-Sep-12 08:53 ET
More Medicine, but Will it Work?

European stock exchanges are up about 1% and S&P futures indicate an up open of about nine points after European Central Bank President Draghi announced that there will be a European program for conditional purchases of government bonds.  Full details were not available as of this posting but the conditions appear to be fairly strict. 

The intention of making it easier for Spain and Italy to finance their deficits amounts to a prescription of painkillers rather than something that will ultimately cure the illness.  The symptom of pain from high interest rates may ease, but this program won't help Spain, Italy, Greece, or any other country approach long-term fiscal stability or increase competitiveness. 

The financial markets are hopeful that the bond buying program will buy time for Europe to address longer-term problems and thus help improve the fundamentals for equities.  There is also no doubt that the risk of a credit market implosion or a euro-breakup is alleviated by this program.  The bounce in the stock market is therefore understandable, but the problem of deepening recession in Europe still exists. 

ADP reported a strong 201,000 gain in August employment.  This is a mixed bag for the stock market.  It suggests that that August payroll gain to be reported Friday will be above current forecasts of just 140,000.  A larger payroll gain would be good for the economy, but reduces (perhaps greatly) the likelihood that the Fed will vote in favor of further quantitative easing at the September meeting.

The S&P 500 index has been in a fairly tight 1400 to 1420 range the past month.  Bullish support from expected central bank action has been offset by a worsening outlook for earnings and worrisome global economic trends.  The painkillers are certainly helping, and are arguably a valid prescription.  Eventually, however, the underlying fundamentals need to improve before global economies and stock markets are truly healthy again.  It still is far from clear that the fundamentals will improve as much as the stock market is anticipating. 

Dick Green

Founder and Chairman, Briefing.com

 

 

 

European stock exchanges are up about 1% and S&P futures indicate an up open of about nine points after European Central Bank President Draghi
 
Add this to my Page Alerts.
MARKET PLACE
SPONSORED LINKS
 
  Follow Us On Linkedin  
 
 
LOGIN

CONTACT US
Support
Sitemap
PREMIUM SERVICES
Take a Tour
Compare Services
Custom Tickers
INSTITUTIONAL SALES
ADVERTISING

CONTENT LICENSING

EMAILS & NEWSLETTERS
ABOUT US
Our Experts
Management Team

COMMUNITY
MEDIA
Events
News
Awards
PRIVACY STATEMENT
Reader Agreement
Policies
Disclaimer
Copyright © Briefing.com, Inc. All rights reserved.
Close
You must log in or register to access this area.
Tip of the Day
Virtual Url Page Popup